Search company, investor...
Cardiolyse company logo


Founded Year



Biz Plan Competition | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+10 points in the past 30 days

About Cardiolyse

Cardiolyse is an e-healthcare company. It focuses on analytics of the human heart and electro signals providing cardio care. Cardiolyse addresses early cardiovascular disease detection or prevention through a post-discharge and chronic cardiovascular disease (CVD) patient monitoring platform. The company was founded in 2015 and is based in Helsinki, Finland.

Headquarters Location

2 Kuortaneenkatu GE Health Innovation Village

Helsinki, 00510,


Missing: Cardiolyse's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cardiolyse's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cardiolyse Patents

Cardiolyse has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Cardiac arrhythmia, Cardiac electrophysiology, Heart diseases, Cardiology, Cardiovascular physiology


Application Date


Grant Date



Related Topics

Cardiac arrhythmia, Cardiac electrophysiology, Heart diseases, Cardiology, Cardiovascular physiology



Latest Cardiolyse News

Remote monitoring can predict a stroke two months before it occurs

Jun 10, 2022

Cardiolyse enables remote vital sign monitoring and personalized patient reports for early diagnostics of cardiovascular disease (CVD) patients – basically it can predict a stroke two months before it occurs. – Cardiolyse adds value to primary as well as secondary prevention, giving early signs to healthcare professionals and engaging patient self-managed care says Normunds Daudiss, […]

Cardiolyse Frequently Asked Questions (FAQ)

  • When was Cardiolyse founded?

    Cardiolyse was founded in 2015.

  • Where is Cardiolyse's headquarters?

    Cardiolyse's headquarters is located at 2 Kuortaneenkatu, Helsinki.

  • What is Cardiolyse's latest funding round?

    Cardiolyse's latest funding round is Biz Plan Competition.

  • Who are the investors of Cardiolyse?

    Investors of Cardiolyse include Health Longevity Global Grand Challenge, Google for Startups Accelerator, Startupbootcamp Digital Health and Vertical Accelerator.

  • Who are Cardiolyse's competitors?

    Competitors of Cardiolyse include Cardiomatics.

Compare Cardiolyse to Competitors

Idoven Logo

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. Its AI-powered platform, Willem, delivers improvements to the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and prediction and the proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers for patient identification, risk stratification, and prognosis, as well as drug cardiac safety monitoring. The company was founded in 2018 and is based in Madrid, Spain.


Cardiolund provides software products for advanced ECG analysis. It offers software for automated ECG beats and rhythm analysis, as well as clinical research software for tracking the atrial fibrillatory frequency (AFR). It was founded in 2010 and is based in Lund, Sweden.


CardioAI is focused on providing deep learning technology to real-life products for natural language processing and healthcare. It offers productivity tools for clinical diagnosis, remote patient monitoring, and off-the-shelf software for digital health applications and devices. It was founded in 2015 and is based in Riga, Latvia.

Cardiomatics Logo

Cardiomatics is a cloud AI tool for ECG analysis and is based in Poland.

Cardiologs Logo

CardioLogs provides a software technology enabling any healthcare professional to accurately and reliably screen patients for cardiovascular diseases. CardioLogs leverages machine learning technology and medical expertise to deliver top ECG interpretation services. On November 8th, 2021, Cardiologs was acquired by Philips. Terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.